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Unexpected Results AGAIN from the
Women’s Health Initiative — Low-Fat Diet
Study Results
Following an eating pattern lower in total fat did
not significantly reduce the incidence of breast
cancer, heart disease, or stroke, and did not reduce
the risk of colorectal cancer in healthy postmeno-
pausal women, according to the latest clinical trial
results from the National Institutes of Health’s
Women’s Health Initiative (WHI).doi:10.1016/j.ijgo.2006.02.010
E-mail addresses: trbj@umich.edu (T.R.B. Johnson)8
rmadanu@yahoo.com (R.M.K. Adanu).The study was designed to evaluate a low-fat
dietary pattern’s effect on the risk of cancer.
However, investigators also evaluated the data to
review the effect on cardiovascular disease. The
results from the largest ever clinical trial of low-fat
diet are reported in three papers in the February
8 edition of the Journal of the American Medical
Association.
Among the 48,835 women who participated in the
trial, there were no significant differences in the
rates of colorectal cancer, heart disease, or stroke
between the group who followed a low-fat dietary
plan and the comparison group who followed their
normal dietary patterns. Although the women in
the study who reduced their total fat intake had a
9% lower risk of breast cancer than did women
who made no dietary changes, the difference was
not large enough to be statistically significant—
meaning it could have been due to chance.
By the end of the first year, the low-fat diet
group reduced average total fat intakes to 24% of
calories from fat, but did not meet the study’s goal
of 20%. At year six, the low-fat diet group was
consuming 29% of calories from fat. The comparison
group averaged 35% of calories from fat at year one
and 37% at year six. Women in both groups started
at 35—38% of calories from fat. The low-fat diet
group also increased their consumption of vegeta-
bles, fruits, and grains.International Journal of Gynecology and Obstetrics (2006) 93, 2—4
CONTEMPORARY 3Women were aged 50—79 at trial enrollment in
1993—98 and were followed for an average of
8.1years. The study diet focused on reducing total
fat, and unlike diets used to reduce heart disease
risk, did not differentiate between bgood fatsQ
found in fish, nuts, and vegetable oils, and bbadQ
fats like saturated fat and trans fat found in
processed foods, meats, and some dairy products.
The study design reflected a widely believed but
untested theory that reduction of total fat would
reduce risks of breast or colorectal cancers. For
heart disease, it was anticipated that reduction in
total fat would be accompanied by a reduction in
saturated fats, which are known to contribute to
heart disease risk.
bThe results of this study do not change estab-
lished recommendations on disease prevention.
Women should continue to get regular mammo-
grams and screenings for colorectal cancer, and
work with their doctors to reduce their risks for
heart disease including following a diet low in
saturated fat, trans fat and cholesterol,Q said
National Heart, Lung, and Blood Institute Director
Elizabeth G. Nabel, M.D.
The study also found that following a high-
carbohydrate, low-fat eating pattern does not
increase body weight, triglycerides or indicators
of increased risk of diabetes such as blood glucose
or insulin levels in women.
The WHI is the most comprehensive study to
date of the causes and prevention of the major
diseases affecting the health of older women.
Over 15years, the study’s findings on heart
disease, breast and colorectal cancer, and osteo-
porosis have stimulated many changes in clinical
practice. The WHI is also one of the largest studies
of its kind ever undertaken in the United States
and is considered a model for future studies of
women’s health.
This study of low-fat dietary pattern is one of the
three randomized clinical trials that make up the
WHI. The others included trials of hormone thera-
py—estrogen plus progestin and estrogen alone.
Both trials were stopped early, estrogen plus
progestin in 2002 and estrogen alone in 2004
because of increased risk of diseases like stroke,
blood clots, and breast cancer. Results of a third
clinical trial studying the effects of calcium and
Vitamin D supplementation on osteoporosis-related
bone fractures and on colorectal cancer will be
published in February 2006.
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295:629—42.Contraception Website Wins United
Nations Award
A website on contraception and sexual health run
by doctors at Queen’s University in Ontario, Can-
ada, has been ranked in the top five e-health sites
in a United Nations (UN) competition. (http://
www.sexualityandu.ca).
The interactive bilingual site, which was picked
from the submissions of 168 countries, targets
adolescents, adults, parents, teachers, and health-
care professionals with information and answers to
submitted questions about contraception, safe sex
practices, and sexual well-being.
As well as responding to emailed questions and
updating the sites dContraceptive FAQ Hotline,T
members of the Contraception Advice Research
and Education fellowship at Queen’s University
distribute a monthly e-newsletter to subscribers
covering breaking news in the areas of contracep-
tion and reproductive health.
The site was created as part of a wider
Contraception Awareness Program, led by Queen’s
fertility expert Dr. Robert Reid, and launched in
2000 by the Society of Obstetricians and Gynecol-
ogists in Canada in response to rising rates of
sexually transmitted infections and unintended
pregnancies in young Canadians.
Other services provided by the Program include
workshops and resources for doctors to help them
improve their communication skills in order to
better assess their patient’s needs and provide
advice about unsafe sexual behavior.
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Cervical Cancer Vaccine Success
A cervical cancer vaccine has proven 100% effective
in preventing tumors caused by the two most
T.R.B. Johnson, R.M.K. Adanu4oncogenic forms of human papillomavirus in final-
stage clinical trials.
Professor Ian Frazer, from the University of
Queensland in Australia, and a pioneer in the work
that led to the vaccine’s development, praised the
results. bIt is very rare, almost unheard of, to
achieve a 100% efficacy rate in any treatment, so
these results are truly wonderful,Q he said.
The vaccine, called GARDASIL, is due to be
submitted for approval by the United States Food
and Drug Administration with anticipated commer-
cial availability in early 2006.
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Breast Cancer Survival dSoarsT
More good news for cancer has been revealed in an
announcement by the UK cancer charity Cancer
Research UK, predicting that nearly two thirds of
women in the UK who are diagnosed with breast
cancer today will survive for 20 years.
Cancer Research UK epidemiologist Professor
Michael Coleman said: bOverall long-term survival
for women with breast cancer has improved
dramatically over the last 10years and we are
seeing even better survival statistics for women in
their fifties and sixtiesQ.
Professor Tony Howell, a Cancer Research UK
oncologist, said: bThese results are highly encour-aging for women who are worried about their
cancer coming backQ. They will also encourage
women to be screened, he said, as women with
screen-detected cancers bfared particularly wellQ.
Improved screening and treatment are two factors
believed to be responsible for the improvements.
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Misoprostol Use in Obstetrics and
Gynecology
Research results indicate that misoprostol can be
an effective intervention for spontaneous and
inducted abortions, cervical ripening, and induc-
tion of labor. Additional research is needed on its
effectiveness for other obstetric and gynecologic
indications.
The benefits of misoprostol use could be partic-
ularly relevant for low-resource settings, where
women face significant morbidity and mortality
from unsafe abortion and a lack of adequate
obstetric care. If misoprostol is to be safely used
in these settings, women and health care providers
need clear and uniform guidelines. With evidence-
based information on misoprostol administration,
health care providers could save the lives of
thousands of women who would otherwise undergo
unsafe interventions or no interventions at all.
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